API

Showing 97–108 of 214 results

• 
  API

  Lanreotide

  CAS:108736-35-2

  Status:DMF (2025)

  Indications:Tumors, as well as endocrine, nutritional, and metabolic diseases
• 
  API

  Lanthanum Carbonate

  CAS: 54451-24-0
  Status:Validated

• 
  API

  Lenvatinib mesylate

  CAS:857890-39-2

• 
  API

  Leuprorelin

  CAS:53714-56-0

  Status:CEP

  Indications:Tumors and diseases of the urogenital system
• 
  API

  Levobupivacaine HCl

  CAS: 27262-48-2
  Status:Validated

• 
  API

  Levosimendan

  CAS: 141505-33-1
  Status:Validated
  Certificate:WC

• 
  API

  Linaclotide

  CAS:851199-59-2

  Status:DMF, NMPA, WC

  Indications:Diseases of the digestive system
• 
  API

  Linzagolix choline

  CAS: 1321816-57-2
  Status:Pilot

   

   

• 
  API

  Liraglutide

  CAS:204656-20-2
  Status:DMF, TGA, NMPA, WC
  Indications:Endocrine, nutritional, and metabolic diseases

• 
  API

  Lumasiran Sodium

  CAS:1834612-06-4

• 
  ADC

  Maytansinol

• 
  ADC

  MC-MMAF